Factors associated with return to work of breast cancer survivors: a systematic review
Background The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer sur...
Uloženo v:
| Vydáno v: | BMC public health Ročník 14; číslo Suppl 3; s. S8 |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
BioMed Central
24.11.2014
BioMed Central Ltd Springer Nature B.V |
| Témata: | |
| ISSN: | 1471-2458, 1471-2458 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background
The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer survivors who return to work (RTW) and the factors associated to RTW.
Methods
A computer based literature search was carried out. "PubMed, Cochrane Library, Embase, Web of Science, and Science Direct" databases were searched systematically. Our search strategy identified a total of 12,116 papers of which 26 studies met the inclusion criteria and quality assessment. These were original papers published between January 2003 and January 2013.
Results
The trends in RTW differ among countries for the breast cancer survivors. The time to RTW after successful cancer treatment also varies among the countries and by ethnicity. The prevalence of the RTW varies from 43% to 93% within one year of diagnosis. The prevalence of the RTW for the Netherland is the lowest in the world (43%). The United States survivors showed the highest RTW (93%) within 12 months of the diagnosis. Numerous barriers and facilitators were identified as factors that affect RTW. For instance, socio-demographic factors such as education and ethnicity; treatment oriented factors such as chemotherapy; work related factors such as heavy physical work; disease related factors such as poor health condition and fatigue; and psychological factors such as depression and emotional distress, act as barriers of RTW. In contrast, social, family, employer support, and financial independency emerge as key facilitators in enabling breast cancer survivors to return and continue work.
Conclusion
Minimising these identified barriers and strengthening these facilitators could further improve the work condition and increase the percentage of RTW among the breast cancer survivors. |
|---|---|
| AbstractList | The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer survivors who return to work (RTW) and the factors associated to RTW. A computer based literature search was carried out. "PubMed, Cochrane Library, Embase, Web of Science, and Science Direct" databases were searched systematically. Our search strategy identified a total of 12,116 papers of which 26 studies met the inclusion criteria and quality assessment. These were original papers published between January 2003 and January 2013. The trends in RTW differ among countries for the breast cancer survivors. The time to RTW after successful cancer treatment also varies among the countries and by ethnicity. The prevalence of the RTW varies from 43% to 93% within one year of diagnosis. The prevalence of the RTW for the Netherland is the lowest in the world (43%). The United States survivors showed the highest RTW (93%) within 12 months of the diagnosis. Numerous barriers and facilitators were identified as factors that affect RTW. For instance, socio-demographic factors such as education and ethnicity; treatment oriented factors such as chemotherapy; work related factors such as heavy physical work; disease related factors such as poor health condition and fatigue; and psychological factors such as depression and emotional distress, act as barriers of RTW. In contrast, social, family, employer support, and financial independency emerge as key facilitators in enabling breast cancer survivors to return and continue work. Minimising these identified barriers and strengthening these facilitators could further improve the work condition and increase the percentage of RTW among the breast cancer survivors. Background The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer survivors who return to work (RTW) and the factors associated to RTW. Methods A computer based literature search was carried out. "PubMed, Cochrane Library, Embase, Web of Science, and Science Direct" databases were searched systematically. Our search strategy identified a total of 12,116 papers of which 26 studies met the inclusion criteria and quality assessment. These were original papers published between January 2003 and January 2013. Results The trends in RTW differ among countries for the breast cancer survivors. The time to RTW after successful cancer treatment also varies among the countries and by ethnicity. The prevalence of the RTW varies from 43% to 93% within one year of diagnosis. The prevalence of the RTW for the Netherland is the lowest in the world (43%). The United States survivors showed the highest RTW (93%) within 12 months of the diagnosis. Numerous barriers and facilitators were identified as factors that affect RTW. For instance, socio-demographic factors such as education and ethnicity; treatment oriented factors such as chemotherapy; work related factors such as heavy physical work; disease related factors such as poor health condition and fatigue; and psychological factors such as depression and emotional distress, act as barriers of RTW. In contrast, social, family, employer support, and financial independency emerge as key facilitators in enabling breast cancer survivors to return and continue work. Conclusion Minimising these identified barriers and strengthening these facilitators could further improve the work condition and increase the percentage of RTW among the breast cancer survivors. Doc number: S8 Abstract Background: The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer survivors who return to work (RTW) and the factors associated to RTW. Methods: A computer based literature search was carried out. "PubMed, Cochrane Library, Embase, Web of Science, and Science Direct" databases were searched systematically. Our search strategy identified a total of 12,116 papers of which 26 studies met the inclusion criteria and quality assessment. These were original papers published between January 2003 and January 2013. Results: The trends in RTW differ among countries for the breast cancer survivors. The time to RTW after successful cancer treatment also varies among the countries and by ethnicity. The prevalence of the RTW varies from 43% to 93% within one year of diagnosis. The prevalence of the RTW for the Netherland is the lowest in the world (43%). The United States survivors showed the highest RTW (93%) within 12 months of the diagnosis. Numerous barriers and facilitators were identified as factors that affect RTW. For instance, socio-demographic factors such as education and ethnicity; treatment oriented factors such as chemotherapy; work related factors such as heavy physical work; disease related factors such as poor health condition and fatigue; and psychological factors such as depression and emotional distress, act as barriers of RTW. In contrast, social, family, employer support, and financial independency emerge as key facilitators in enabling breast cancer survivors to return and continue work. Conclusion: Minimising these identified barriers and strengthening these facilitators could further improve the work condition and increase the percentage of RTW among the breast cancer survivors. Background: The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer survivors who return to work (RTW) and the factors associated to RTW. Methods: A computer based literature search was carried out. "PubMed, Cochrane Library, Embase, Web of Science, and Science Direct" databases were searched systematically. Our search strategy identified a total of 12,116 papers of which 26 studies met the inclusion criteria and quality assessment. These were original papers published between January 2003 and January 2013. Results: The trends in RTW differ among countries for the breast cancer survivors. The time to RTW after successful cancer treatment also varies among the countries and by ethnicity. The prevalence of the RTW varies from 43% to 93% within one year of diagnosis. The prevalence of the RTW for the Netherland is the lowest in the world (43%). The United States survivors showed the highest RTW (93%) within 12 months of the diagnosis. Numerous barriers and facilitators were identified as factors that affect RTW. For instance, socio-demographic factors such as education and ethnicity; treatment oriented factors such as chemotherapy; work related factors such as heavy physical work; disease related factors such as poor health condition and fatigue; and psychological factors such as depression and emotional distress, act as barriers of RTW. In contrast, social, family, employer support, and financial independency emerge as key facilitators in enabling breast cancer survivors to return and continue work. Conclusion: Minimising these identified barriers and strengthening these facilitators could further improve the work condition and increase the percentage of RTW among the breast cancer survivors. Background The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer survivors who return to work (RTW) and the factors associated to RTW. Methods A computer based literature search was carried out. "PubMed, Cochrane Library, Embase, Web of Science, and Science Direct" databases were searched systematically. Our search strategy identified a total of 12,116 papers of which 26 studies met the inclusion criteria and quality assessment. These were original papers published between January 2003 and January 2013. Results The trends in RTW differ among countries for the breast cancer survivors. The time to RTW after successful cancer treatment also varies among the countries and by ethnicity. The prevalence of the RTW varies from 43% to 93% within one year of diagnosis. The prevalence of the RTW for the Netherland is the lowest in the world (43%). The United States survivors showed the highest RTW (93%) within 12 months of the diagnosis. Numerous barriers and facilitators were identified as factors that affect RTW. For instance, socio-demographic factors such as education and ethnicity; treatment oriented factors such as chemotherapy; work related factors such as heavy physical work; disease related factors such as poor health condition and fatigue; and psychological factors such as depression and emotional distress, act as barriers of RTW. In contrast, social, family, employer support, and financial independency emerge as key facilitators in enabling breast cancer survivors to return and continue work. Conclusion Minimising these identified barriers and strengthening these facilitators could further improve the work condition and increase the percentage of RTW among the breast cancer survivors. Keywords: Breast cancer, employment, work, barriers, facilitators, return to work (RTW) The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer survivors who return to work (RTW) and the factors associated to RTW. A computer based literature search was carried out. "PubMed, Cochrane Library, Embase, Web of Science, and Science Direct" databases were searched systematically. Our search strategy identified a total of 12,116 papers of which 26 studies met the inclusion criteria and quality assessment. These were original papers published between January 2003 and January 2013. The trends in RTW differ among countries for the breast cancer survivors. The time to RTW after successful cancer treatment also varies among the countries and by ethnicity. The prevalence of the RTW varies from 43% to 93% within one year of diagnosis. The prevalence of the RTW for the Netherland is the lowest in the world (43%). The United States survivors showed the highest RTW (93%) within 12 months of the diagnosis. Numerous barriers and facilitators were identified as factors that affect RTW. For instance, socio-demographic factors such as education and ethnicity; treatment oriented factors such as chemotherapy; work related factors such as heavy physical work; disease related factors such as poor health condition and fatigue; and psychological factors such as depression and emotional distress, act as barriers of RTW. In contrast, social, family, employer support, and financial independency emerge as key facilitators in enabling breast cancer survivors to return and continue work. Minimising these identified barriers and strengthening these facilitators could further improve the work condition and increase the percentage of RTW among the breast cancer survivors. The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer survivors who return to work (RTW) and the factors associated to RTW.BACKGROUNDThe breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in regards to economy and rehabilitation. The aim of this systematic review study is to identify the prevalence of breast cancer survivors who return to work (RTW) and the factors associated to RTW.A computer based literature search was carried out. "PubMed, Cochrane Library, Embase, Web of Science, and Science Direct" databases were searched systematically. Our search strategy identified a total of 12,116 papers of which 26 studies met the inclusion criteria and quality assessment. These were original papers published between January 2003 and January 2013.METHODSA computer based literature search was carried out. "PubMed, Cochrane Library, Embase, Web of Science, and Science Direct" databases were searched systematically. Our search strategy identified a total of 12,116 papers of which 26 studies met the inclusion criteria and quality assessment. These were original papers published between January 2003 and January 2013.The trends in RTW differ among countries for the breast cancer survivors. The time to RTW after successful cancer treatment also varies among the countries and by ethnicity. The prevalence of the RTW varies from 43% to 93% within one year of diagnosis. The prevalence of the RTW for the Netherland is the lowest in the world (43%). The United States survivors showed the highest RTW (93%) within 12 months of the diagnosis. Numerous barriers and facilitators were identified as factors that affect RTW. For instance, socio-demographic factors such as education and ethnicity; treatment oriented factors such as chemotherapy; work related factors such as heavy physical work; disease related factors such as poor health condition and fatigue; and psychological factors such as depression and emotional distress, act as barriers of RTW. In contrast, social, family, employer support, and financial independency emerge as key facilitators in enabling breast cancer survivors to return and continue work.RESULTSThe trends in RTW differ among countries for the breast cancer survivors. The time to RTW after successful cancer treatment also varies among the countries and by ethnicity. The prevalence of the RTW varies from 43% to 93% within one year of diagnosis. The prevalence of the RTW for the Netherland is the lowest in the world (43%). The United States survivors showed the highest RTW (93%) within 12 months of the diagnosis. Numerous barriers and facilitators were identified as factors that affect RTW. For instance, socio-demographic factors such as education and ethnicity; treatment oriented factors such as chemotherapy; work related factors such as heavy physical work; disease related factors such as poor health condition and fatigue; and psychological factors such as depression and emotional distress, act as barriers of RTW. In contrast, social, family, employer support, and financial independency emerge as key facilitators in enabling breast cancer survivors to return and continue work.Minimising these identified barriers and strengthening these facilitators could further improve the work condition and increase the percentage of RTW among the breast cancer survivors.CONCLUSIONMinimising these identified barriers and strengthening these facilitators could further improve the work condition and increase the percentage of RTW among the breast cancer survivors. |
| ArticleNumber | S8 |
| Audience | Academic |
| Author | Dahlui, Maznah Su, Tin Tin Nahar, Azmi Mohamed Mohd Taib, Nur Aishah Islam, Tania Majid, Hazreen Abd |
| AuthorAffiliation | 2 Department of Sports Medicine, Faculty of Medicine, University of Malaya, Malaysia 1 Centre for Population Health (CePH), Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Malaysia 3 Department of Surgery, Faculty of Medicine, University of Malaya, Malaysia |
| AuthorAffiliation_xml | – name: 1 Centre for Population Health (CePH), Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Malaysia – name: 3 Department of Surgery, Faculty of Medicine, University of Malaya, Malaysia – name: 2 Department of Sports Medicine, Faculty of Medicine, University of Malaya, Malaysia |
| Author_xml | – sequence: 1 givenname: Tania surname: Islam fullname: Islam, Tania organization: Centre for Population Health (CePH), Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Department of Surgery, Faculty of Medicine, University of Malaya – sequence: 2 givenname: Maznah surname: Dahlui fullname: Dahlui, Maznah organization: Centre for Population Health (CePH), Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya – sequence: 3 givenname: Hazreen Abd surname: Majid fullname: Majid, Hazreen Abd organization: Centre for Population Health (CePH), Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya – sequence: 4 givenname: Azmi Mohamed surname: Nahar fullname: Nahar, Azmi Mohamed organization: Department of Sports Medicine, Faculty of Medicine, University of Malaya – sequence: 5 givenname: Nur Aishah surname: Mohd Taib fullname: Mohd Taib, Nur Aishah organization: Department of Surgery, Faculty of Medicine, University of Malaya – sequence: 6 givenname: Tin Tin surname: Su fullname: Su, Tin Tin email: tintinsu03@yahoo.com organization: Centre for Population Health (CePH), Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25437351$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1v1DAQhiNURD_gD3BAlrhwSfFnYnNAqipKkSpxWOBqeZ3x1iWJi-3sqv8eR9uuthUf8sGj8fOOR-_McXUwhhGq6jXBp4TI5j3hLakpF7ImvF6weiGfVUe75MFefFgdp3SDMWmloC-qQyo4a5kgR9WPC2NziAmZlIL1JkOHNj5fowh5iiPKAW1C_ImCQ8sIJmVkzWghojTFtV8X5QdkULpLGQaTvS26tYfNy-q5M32CV_f3SfX94tO388v66uvnL-dnV7UVLc-1s9ZwyrDqBCO0aQjGS4mBgsNLwZ2iwDAjWCnuQHWq66TjogMwzLWcdIydVB-3dW-n5QCdhTFH0-vb6AcT73QwXj9-Gf21XoW15lQQwlQp8O6-QAy_JkhZDz5Z6HszQpiSJg0TmAlW-vg_SpUSCmNR0LdP0JtQ3CxOzFTbSiXkHrUyPWg_ulBatHNRfSaYahQmcu7w9A9UOR0M3paNcL7kHwne7HuyM-Nh6AWgW8DGkFIEt0MI1vNm6Xlx9Lw4JdILpheyiOQTkfW5TDzMvvr-31K2labyz7iCuOfG31W_AQfo4ac |
| CitedBy_id | crossref_primary_10_1007_s00520_018_4343_6 crossref_primary_10_1097_PPO_0000000000000505 crossref_primary_10_1002_cam4_3512 crossref_primary_10_3233_WOR_203342 crossref_primary_10_1016_j_maturitas_2017_04_013 crossref_primary_10_1177_10547738221106292 crossref_primary_10_1007_s10926_020_09951_6 crossref_primary_10_1111_scs_12502 crossref_primary_10_1002_cncr_31270 crossref_primary_10_3390_cancers12020355 crossref_primary_10_1097_NCC_0000000000001449 crossref_primary_10_1111_jan_14730 crossref_primary_10_1097_PHM_0000000000001017 crossref_primary_10_1016_j_maturitas_2024_107920 crossref_primary_10_1186_s12889_020_09562_z crossref_primary_10_1002_cncr_29511 crossref_primary_10_1111_ecc_13051 crossref_primary_10_1007_s00520_016_3239_6 crossref_primary_10_1007_s11764_024_01576_5 crossref_primary_10_1177_1403494817722291 crossref_primary_10_3233_WOR_210421 crossref_primary_10_1007_s00520_018_4092_6 crossref_primary_10_3389_fpsyg_2022_866346 crossref_primary_10_1111_ecc_13626 crossref_primary_10_1007_s10926_022_10052_9 crossref_primary_10_1007_s11764_019_00844_z crossref_primary_10_1155_2024_2671255 crossref_primary_10_3389_fpubh_2018_00035 crossref_primary_10_1016_j_ejon_2024_102593 crossref_primary_10_1002_pon_5802 crossref_primary_10_1177_1054137315620092 crossref_primary_10_2147_JMDH_S498387 crossref_primary_10_3389_fpubh_2022_1000892 crossref_primary_10_1007_s10926_018_9789_3 crossref_primary_10_1038_bjc_2015_431 crossref_primary_10_1111_scs_12646 crossref_primary_10_1080_09638288_2018_1555621 crossref_primary_10_1007_s11764_023_01451_9 crossref_primary_10_1080_09638288_2016_1219924 crossref_primary_10_1007_s00277_016_2806_8 crossref_primary_10_1007_s00520_022_07570_w crossref_primary_10_1177_08901171211061939 crossref_primary_10_1080_07347332_2020_1856282 crossref_primary_10_1080_09638288_2017_1300950 crossref_primary_10_1016_j_breast_2018_03_002 crossref_primary_10_1007_s00520_024_08500_8 crossref_primary_10_1177_0950017020955092 crossref_primary_10_1016_j_breast_2018_12_013 crossref_primary_10_1007_s40141_017_0145_x crossref_primary_10_1007_s00520_022_06913_x crossref_primary_10_1007_s11764_022_01179_y crossref_primary_10_1007_s10354_018_0619_1 crossref_primary_10_1186_s41927_023_00365_4 crossref_primary_10_1016_j_jcpo_2025_100558 crossref_primary_10_1186_s12885_018_4668_z crossref_primary_10_1002_cam4_3952 crossref_primary_10_3390_healthcare12232433 crossref_primary_10_1186_s12885_024_12796_4 crossref_primary_10_7759_cureus_92301 crossref_primary_10_1007_s10926_020_09881_3 crossref_primary_10_1186_s12916_016_0768_2 crossref_primary_10_7202_1118004ar crossref_primary_10_1016_j_breast_2018_04_009 crossref_primary_10_1186_s13063_020_04288_0 crossref_primary_10_1016_j_jpainsymman_2018_12_003 crossref_primary_10_1080_09638288_2020_1759150 crossref_primary_10_1111_ecc_12793 crossref_primary_10_3233_WOR_213623 crossref_primary_10_1007_s00520_025_09364_2 crossref_primary_10_3389_fpsyg_2022_910779 crossref_primary_10_4069_whn_2024_12_10 crossref_primary_10_1186_s12875_022_01768_x crossref_primary_10_1007_s00520_025_09349_1 crossref_primary_10_1007_s10198_023_01618_2 crossref_primary_10_1007_s11764_024_01598_z crossref_primary_10_1007_s00520_022_07436_1 crossref_primary_10_1002_cam4_70404 crossref_primary_10_1186_s13104_020_05218_8 crossref_primary_10_1080_13548506_2020_1795212 crossref_primary_10_3233_WOR_182810 crossref_primary_10_1016_j_breast_2019_01_006 crossref_primary_10_1093_ptj_pzz184 crossref_primary_10_1007_s00520_021_06097_w crossref_primary_10_1007_s10926_016_9641_6 crossref_primary_10_1007_s11764_023_01469_z crossref_primary_10_1007_s11764_021_01053_3 crossref_primary_10_2340_1651_226X_2025_44017 crossref_primary_10_3390_ijerph17228608 crossref_primary_10_1186_s12905_015_0166_5 crossref_primary_10_3389_fpubh_2022_954247 crossref_primary_10_1007_s00520_022_07000_x crossref_primary_10_1007_s00520_021_06354_y crossref_primary_10_1186_s12913_023_09714_y crossref_primary_10_1007_s00520_019_4660_4 crossref_primary_10_1007_s11764_020_00906_7 crossref_primary_10_1007_s10549_023_06968_2 crossref_primary_10_1016_j_ygyno_2020_10_041 crossref_primary_10_1136_bmjopen_2023_073802 crossref_primary_10_1007_s11764_022_01222_y crossref_primary_10_1002_cam4_3623 crossref_primary_10_1080_09638288_2019_1590468 crossref_primary_10_1017_S0714980819000187 crossref_primary_10_1055_a_2006_4248 crossref_primary_10_1002_cncr_33913 crossref_primary_10_1177_1359105320913946 crossref_primary_10_1002_cncr_32820 crossref_primary_10_1371_journal_pone_0277982 crossref_primary_10_3389_fpsyg_2023_1275331 crossref_primary_10_1007_s00520_017_3987_y crossref_primary_10_1186_s12885_016_2627_0 crossref_primary_10_1093_occmed_kqz024 crossref_primary_10_1186_s12885_022_09224_w crossref_primary_10_1016_j_pmrj_2017_06_019 crossref_primary_10_1038_s41415_025_8456_2 crossref_primary_10_1186_s12885_021_08613_x crossref_primary_10_1007_s10926_023_10169_5 crossref_primary_10_3390_cancers13122868 crossref_primary_10_1007_s40271_020_00472_1 crossref_primary_10_1016_j_apmr_2016_12_022 crossref_primary_10_1007_s11764_017_0664_6 crossref_primary_10_3390_healthcare11162343 crossref_primary_10_1188_20_ONF_89_100 crossref_primary_10_1007_s11764_021_01035_5 crossref_primary_10_1016_j_ejon_2019_06_004 crossref_primary_10_1186_s12889_022_13023_0 crossref_primary_10_1093_jncics_pky064 crossref_primary_10_1186_s12905_020_01125_z crossref_primary_10_1093_jjco_hyy088 crossref_primary_10_1007_s00520_019_04799_w crossref_primary_10_1080_09638288_2025_2451213 crossref_primary_10_3390_ijerph182010703 crossref_primary_10_1186_s12885_021_07824_6 crossref_primary_10_1200_JCO_2017_77_3663 crossref_primary_10_1177_21650799241303524 crossref_primary_10_1007_s00761_024_01501_6 crossref_primary_10_1007_s10926_023_10101_x crossref_primary_10_1002_cncr_32643 crossref_primary_10_1111_hsc_12698 crossref_primary_10_1002_pon_5877 crossref_primary_10_1007_s00520_018_4132_2 crossref_primary_10_3390_ijerph192114418 crossref_primary_10_1002_pon_5753 crossref_primary_10_1080_0284186X_2023_2238886 crossref_primary_10_1007_s11764_024_01557_8 crossref_primary_10_1016_j_ejon_2024_102619 crossref_primary_10_1001_jamanetworkopen_2024_27576 crossref_primary_10_1371_journal_pone_0215662 crossref_primary_10_1002_hed_26123 crossref_primary_10_1007_s10926_018_9800_z crossref_primary_10_1007_s10926_016_9685_7 crossref_primary_10_1007_s10549_020_05632_3 crossref_primary_10_1007_s15015_025_4247_5 crossref_primary_10_1002_pon_5527 crossref_primary_10_1371_journal_pone_0210887 crossref_primary_10_1007_s10926_018_9762_1 crossref_primary_10_1186_s12889_019_6666_8 crossref_primary_10_2196_13150 crossref_primary_10_1007_s00520_022_07449_w crossref_primary_10_1016_j_ctro_2017_11_006 crossref_primary_10_1080_10803548_2022_2044640 crossref_primary_10_1007_s11764_018_0718_4 crossref_primary_10_1007_s13187_020_01760_y crossref_primary_10_1007_s10926_017_9714_1 crossref_primary_10_1111_ecc_13235 crossref_primary_10_1007_s10926_022_10044_9 crossref_primary_10_1007_s11764_020_00862_2 crossref_primary_10_1055_a_1361_4028 crossref_primary_10_1007_s11764_023_01503_0 crossref_primary_10_1016_j_bulcan_2019_10_006 crossref_primary_10_1634_theoncologist_2015_0537 crossref_primary_10_1007_s00520_019_05164_7 crossref_primary_10_1186_s12889_021_10703_1 crossref_primary_10_1186_s12889_021_11357_9 crossref_primary_10_1016_j_breast_2020_06_007 crossref_primary_10_3233_WOR_210008 crossref_primary_10_3322_caac_21548 crossref_primary_10_1002_14651858_CD015124_pub2 crossref_primary_10_1007_s00520_021_06707_7 crossref_primary_10_1177_1043659618771142 crossref_primary_10_1016_j_aprim_2024_103177 crossref_primary_10_1093_jnci_djy172 crossref_primary_10_1016_j_bulcan_2023_01_014 crossref_primary_10_3233_WOR_205044 crossref_primary_10_1080_09638288_2021_2011435 crossref_primary_10_1136_bmjopen_2021_059225 crossref_primary_10_1186_s12882_021_02552_2 crossref_primary_10_1080_09638288_2021_1919216 crossref_primary_10_1007_s00520_024_08622_z crossref_primary_10_1002_pon_5021 crossref_primary_10_1177_03080226251319900 crossref_primary_10_1002_pon_5392 crossref_primary_10_3390_cancers15030874 crossref_primary_10_1007_s10926_021_09978_3 crossref_primary_10_3390_healthcare12070805 crossref_primary_10_1212_WNL_0000000000009982 crossref_primary_10_1371_journal_pone_0278528 crossref_primary_10_1080_0284186X_2023_2254483 crossref_primary_10_1136_bmjopen_2017_020276 crossref_primary_10_1186_s12905_021_01468_1 crossref_primary_10_1007_s10926_015_9620_3 crossref_primary_10_1136_bmjopen_2018_021742 crossref_primary_10_1016_j_jvir_2023_01_029 crossref_primary_10_1007_s00520_021_06422_3 crossref_primary_10_3166_pson_2022_0223 crossref_primary_10_3389_fpubh_2024_1340920 crossref_primary_10_1186_s12913_018_3768_4 crossref_primary_10_3233_WOR_213565 crossref_primary_10_1093_bmb_ldac028 crossref_primary_10_3233_WOR_213563 crossref_primary_10_1200_JCO_2015_66_0613 crossref_primary_10_1186_s12885_021_07812_w crossref_primary_10_1227_neu_0000000000003185 crossref_primary_10_1634_theoncologist_2018_0347 crossref_primary_10_32725_kont_2021_033 crossref_primary_10_1007_s11764_022_01202_2 crossref_primary_10_1007_s00520_018_4453_1 crossref_primary_10_1080_07347332_2023_2233951 crossref_primary_10_1007_s00280_022_04499_z crossref_primary_10_1007_s11764_018_0731_7 crossref_primary_10_1007_s10549_020_05720_4 crossref_primary_10_1016_j_neucli_2017_03_002 crossref_primary_10_1002_pon_5173 crossref_primary_10_1007_s00520_016_3329_5 crossref_primary_10_1080_09638288_2019_1583779 crossref_primary_10_1080_0284186X_2023_2187261 crossref_primary_10_1186_s40359_023_01107_4 crossref_primary_10_1007_s40271_020_00427_6 crossref_primary_10_1097_HNP_0000000000000580 crossref_primary_10_1177_17579759221139860 crossref_primary_10_3109_0284186X_2015_1125015 crossref_primary_10_1007_s12282_020_01211_y crossref_primary_10_1007_s10926_023_10103_9 crossref_primary_10_1016_j_amjsurg_2024_115895 crossref_primary_10_1007_s00520_021_06615_w crossref_primary_10_1186_s12905_022_02116_y |
| Cites_doi | 10.1016/S1470-2045(08)70179-7 10.1007/s10926-011-9342-0 10.7314/APJCP.2012.13.11.5791 10.1007/s10900-011-9509-9 10.1080/02841860802477899 10.1787/082872464507 10.1016/j.critrevonc.2010.01.004 10.1111/j.1471-6712.2012.01046.x 10.1200/JCO.2004.00.4929 10.1503/cmaj.050178 10.1111/j.1365-2354.2008.01043.x 10.3109/0284186X.2012.744877 10.3233/WOR-2011-1137 10.1007/s10549-010-1330-0 10.1093/occmed/kqn092 10.1002/cncr.24301 10.1007/s11764-012-0215-0 10.1093/jnci/djh335 10.5271/sjweh.3199 10.1080/00015458.2003.11679409 10.1186/1471-2407-9-117 10.1200/JCO.2005.09.500 10.1136/bmjqs-2013-002524 10.1080/02841860600857318 10.1111/j.1471-6712.2012.01026.x 10.1016/j.ejon.2011.03.005 10.1007/s10926-009-9215-y 10.1186/1471-2458-12-538 10.1007/s10549-008-0209-9 10.1002/cncr.26478 10.1097/JOM.0b013e318165159e 10.1007/s10926-008-9146-z 10.1371/journal.pone.0074214 |
| ContentType | Journal Article |
| Copyright | Islam et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. COPYRIGHT 2014 BioMed Central Ltd. 2014 Islam et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Copyright © 2014 Islam et al.; licensee BioMed Central Ltd. 2014 Islam et al.; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: Islam et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. – notice: COPYRIGHT 2014 BioMed Central Ltd. – notice: 2014 Islam et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. – notice: Copyright © 2014 Islam et al.; licensee BioMed Central Ltd. 2014 Islam et al.; licensee BioMed Central Ltd. |
| CorporateAuthor | MyBCC study group |
| CorporateAuthor_xml | – name: MyBCC study group |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7X7 7XB 88E 8C1 8FE 8FG 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA AN0 ATCPS AZQEC BENPR BGLVJ BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. L6V M0S M1P M7S PATMY PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY 7X8 5PM |
| DOI | 10.1186/1471-2458-14-S3-S8 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials - QC ProQuest Central Technology collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Engineering Collection ProQuest Health & Medical Collection Medical Database Engineering Database Environmental Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection ProQuest Engineering Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Engineering Database ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Materials Science & Engineering Collection Environmental Science Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database Health & Safety Science Abstracts MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1471-2458 |
| EndPage | S8 |
| ExternalDocumentID | PMC4251139 3507074831 A539690189 25437351 10_1186_1471_2458_14_S3_S8 |
| Genre | Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GeographicLocations | USA Netherlands |
| GeographicLocations_xml | – name: Netherlands – name: USA |
| GroupedDBID | --- 0R~ 23N 2WC 2XV 4.4 44B 53G 5VS 6J9 6PF 7X7 7XC 88E 8C1 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AASML AAWTL ABDBF ABJCF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AN0 AOIJS ATCPS BAPOH BAWUL BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BNQBC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESTFP ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 L6V M1P M48 M7S M~E O5R O5S OK1 OVT P2P PATMY PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PUEGO PYCSY RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION 2VQ ALIPV C1A CGR CUY CVF ECM EIF NPM 3V. 7T2 7XB 8FK AZQEC C1K DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c574t-fcca42309d531266100b80e2ef0b54f92e30310994fe9d9dd8f45deea3f741d33 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 296 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000345688700008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2458 |
| IngestDate | Tue Nov 04 01:56:11 EST 2025 Tue Oct 07 09:23:56 EDT 2025 Sun Nov 09 13:19:04 EST 2025 Sat Oct 11 05:44:26 EDT 2025 Tue Nov 11 10:57:37 EST 2025 Tue Nov 04 18:15:30 EST 2025 Wed Jul 30 01:47:15 EDT 2025 Sat Nov 29 06:22:50 EST 2025 Tue Nov 18 22:16:41 EST 2025 Sat Sep 06 07:35:38 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Suppl 3 |
| Keywords | Breast cancer barriers facilitators employment return to work (RTW) work |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c574t-fcca42309d531266100b80e2ef0b54f92e30310994fe9d9dd8f45deea3f741d33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 ObjectType-Article-2 ObjectType-Conference-1 ObjectType-Feature-3 SourceType-Conference Papers & Proceedings-2 |
| OpenAccessLink | https://link.springer.com/10.1186/1471-2458-14-S3-S8 |
| PMID | 25437351 |
| PQID | 1627789585 |
| PQPubID | 44782 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4251139 proquest_miscellaneous_1635035330 proquest_miscellaneous_1629959005 proquest_journals_1627789585 gale_infotracmisc_A539690189 gale_infotracacademiconefile_A539690189 pubmed_primary_25437351 crossref_primary_10_1186_1471_2458_14_S3_S8 crossref_citationtrail_10_1186_1471_2458_14_S3_S8 springer_journals_10_1186_1471_2458_14_S3_S8 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-11-24 |
| PublicationDateYYYYMMDD | 2014-11-24 |
| PublicationDate_xml | – month: 11 year: 2014 text: 2014-11-24 day: 24 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC public health |
| PublicationTitleAbbrev | BMC Public Health |
| PublicationTitleAlternate | BMC Public Health |
| PublicationYear | 2014 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V |
| References | E Ahn (7276_CR30) 2009; 116 M Drolet (7276_CR19) 2005; 23 MB Boyce (7276_CR34) 2014; 23 A Johnsson (7276_CR21) 2011; 38 7276_CR1 JL Hoving (7276_CR11) 2009; 9 VS Blinder (7276_CR27) 2012; 118 F Jaumotte (7276_CR7) 2003 A Johnsson (7276_CR17) 2010; 19 C Tiedtke (7276_CR10) 2012; 22 RR Bouknight (7276_CR28) 2006; 24 7276_CR36 FL Tan (7276_CR2) 2012; 13 MP Coleman (7276_CR5) 2008; 9 M Nilsson (7276_CR18) 2011; 15 M Drolet (7276_CR20) 2005; 173 7276_CR35 CW William (7276_CR38) 2008 E Hedayati (7276_CR23) 2012; 27 F Balak (7276_CR24) 2008; 18 GM Decker (7276_CR39) 2006; 4 A Johnsson (7276_CR32) 2007; 46 AR Jadad (7276_CR37) 1996 J Ferlay (7276_CR4) 2010 R Molina Villaverde (7276_CR22) 2008; 58 B Hauglann (7276_CR3) 2012; 6 SQ Fantoni (7276_CR8) 2010; 20 CA Roelen (7276_CR29) 2011; 128 MJ Hassett (7276_CR25) 2009; 115 E Maunsell (7276_CR9) 2004; 96 SJ Tamminga (7276_CR14) 2012; 38 P Joanne (7276_CR33) 2013 JA Hansen (7276_CR31) 2008; 50 A Mehnert (7276_CR12) 2011; 77 VS Blinder (7276_CR16) 2012; 37 A Johnsson (7276_CR26) 2009; 48 PH Nagel (7276_CR40) 2003; 103 S Lilliehorn (7276_CR6) 2012; 27 K Carlsen (7276_CR13) 2013; 52 C Tiedtke (7276_CR15) 2012; 12 |
| References_xml | – volume: 9 start-page: 730 issue: 8 year: 2008 ident: 7276_CR5 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(08)70179-7 – volume: 22 start-page: 241 issue: 2 year: 2012 ident: 7276_CR10 publication-title: J Occup Rehabil doi: 10.1007/s10926-011-9342-0 – volume: 13 start-page: 5791 issue: 11 year: 2012 ident: 7276_CR2 publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2012.13.11.5791 – volume: 37 start-page: 763 issue: 4 year: 2012 ident: 7276_CR16 publication-title: J Community Health doi: 10.1007/s10900-011-9509-9 – volume: 48 start-page: 93 issue: 1 year: 2009 ident: 7276_CR26 publication-title: Acta Oncol doi: 10.1080/02841860802477899 – start-page: 2003 volume-title: Female labour force participation: past trends and main determinants in OECD countries year: 2003 ident: 7276_CR7 doi: 10.1787/082872464507 – volume-title: Returning to Work After Breast cancer: A Critical Review International Journal of Disability Management year: 2013 ident: 7276_CR33 – volume: 77 start-page: 109 issue: 2 year: 2011 ident: 7276_CR12 publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2010.01.004 – volume: 27 start-page: 380 issue: 2 year: 2012 ident: 7276_CR23 publication-title: Scand J Caring Sci doi: 10.1111/j.1471-6712.2012.01046.x – volume: 24 start-page: 345 issue: 3 year: 2006 ident: 7276_CR28 publication-title: J Clin Oncol doi: 10.1200/JCO.2004.00.4929 – volume: 173 start-page: 765 issue: 7 year: 2005 ident: 7276_CR20 publication-title: CMAJ doi: 10.1503/cmaj.050178 – volume: 19 start-page: 317 issue: 3 year: 2010 ident: 7276_CR17 publication-title: Eur J Cancer Care (Engl) doi: 10.1111/j.1365-2354.2008.01043.x – volume-title: Emerging Themes in Epidemiology year: 2008 ident: 7276_CR38 – volume: 52 start-page: 423 issue: 2 year: 2013 ident: 7276_CR13 publication-title: Acta Oncol doi: 10.3109/0284186X.2012.744877 – volume: 38 start-page: 337 issue: 4 year: 2011 ident: 7276_CR21 publication-title: Work doi: 10.3233/WOR-2011-1137 – volume: 128 start-page: 237 issue: 1 year: 2011 ident: 7276_CR29 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-010-1330-0 – volume-title: Control Clin Trials year: 1996 ident: 7276_CR37 – volume: 58 start-page: 509 issue: 7 year: 2008 ident: 7276_CR22 publication-title: Occup Med (Lond) doi: 10.1093/occmed/kqn092 – volume: 115 start-page: 2775 issue: 12 year: 2009 ident: 7276_CR25 publication-title: Cancer doi: 10.1002/cncr.24301 – volume: 6 start-page: 345 issue: 3 year: 2012 ident: 7276_CR3 publication-title: J Cancer Surviv doi: 10.1007/s11764-012-0215-0 – volume: 96 start-page: 1813 issue: 24 year: 2004 ident: 7276_CR9 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djh335 – volume: 4 start-page: 35 issue: 1 year: 2006 ident: 7276_CR39 publication-title: J Support Oncol – volume: 38 start-page: 144 issue: 2 year: 2012 ident: 7276_CR14 publication-title: Scand J Work Environ Health doi: 10.5271/sjweh.3199 – volume: 103 start-page: 212 issue: 2 year: 2003 ident: 7276_CR40 publication-title: Acta Chir Belg doi: 10.1080/00015458.2003.11679409 – ident: 7276_CR1 – volume: 9 start-page: 117 year: 2009 ident: 7276_CR11 publication-title: BMC Cancer doi: 10.1186/1471-2407-9-117 – volume: 23 start-page: 8305 issue: 33 year: 2005 ident: 7276_CR19 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.09.500 – volume: 23 start-page: 508 issue: 6 year: 2014 ident: 7276_CR34 publication-title: BMJ Qual Saf doi: 10.1136/bmjqs-2013-002524 – ident: 7276_CR36 – volume-title: Lyon, France: International Agency for Research on Cancer year: 2010 ident: 7276_CR4 – volume: 46 start-page: 90 issue: 1 year: 2007 ident: 7276_CR32 publication-title: Acta Oncol doi: 10.1080/02841860600857318 – volume: 27 start-page: 267 issue: 2 year: 2012 ident: 7276_CR6 publication-title: Scand J Caring Sci doi: 10.1111/j.1471-6712.2012.01026.x – volume: 15 start-page: 267 issue: 3 year: 2011 ident: 7276_CR18 publication-title: Eur J Oncol Nurs doi: 10.1016/j.ejon.2011.03.005 – volume: 20 start-page: 49 issue: 1 year: 2010 ident: 7276_CR8 publication-title: J Occup Rehabil doi: 10.1007/s10926-009-9215-y – volume: 12 start-page: 538 year: 2012 ident: 7276_CR15 publication-title: BMC Public Health doi: 10.1186/1471-2458-12-538 – volume: 116 start-page: 609 issue: 3 year: 2009 ident: 7276_CR30 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-008-0209-9 – volume: 118 start-page: 1664 issue: 6 year: 2012 ident: 7276_CR27 publication-title: Cancer doi: 10.1002/cncr.26478 – volume: 50 start-page: 777 issue: 7 year: 2008 ident: 7276_CR31 publication-title: J Occup Environ Med doi: 10.1097/JOM.0b013e318165159e – volume: 18 start-page: 267 issue: 3 year: 2008 ident: 7276_CR24 publication-title: J Occup Rehabil doi: 10.1007/s10926-008-9146-z – ident: 7276_CR35 doi: 10.1371/journal.pone.0074214 |
| SSID | ssj0017852 |
| Score | 2.5660622 |
| SecondaryResourceType | review_article |
| Snippet | Background
The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely... The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely important in... Background The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely... Doc number: S8 Abstract Background: The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing... Background: The breast cancer survival rate is the highest among all types of cancers, and survivors returning to work after completing treatment is extremely... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | S8 |
| SubjectTerms | Biostatistics Breast cancer Breast Neoplasms - complications Breast Neoplasms - therapy Cancer therapies Disability management Employment Environmental Health Epidemiology Female Health care Humans Low income groups Medicine Medicine & Public Health Meta-analysis Population Proceedings Public Health Rehabilitation Return to Work - statistics & numerical data Socioeconomic Factors Studies Survival Survivors - psychology Survivors - statistics & numerical data Vaccine Womens health Work - psychology Work - statistics & numerical data Working conditions |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Ni9QwFH_orAdB_P6orhJB8KBh2yZtEy-yyg4eZFgclb2FTpLigrTrTGf_ft9r0-52wLl4G8jLkPT3vpK8D4A3qRfICbnmXviCS9R_XMcy4S6zufOxRVy6ROGvxWKhzs70abhw24SwykEndoraNZbuyI-SPC0KpdG7_Xjxh1PXKHpdDS00bsIBVSqTMzj4dLI4_Ta-IxQqS4dUGZUfJaiKeSozPDhJvhR8qSbmaFcpX7NKuxGTO8-mnTWa3_vffdyHu8EPZcc94zyAG75-CHf6SzzW5yY9gp_zvhsPKwOI3jG6uGVrj5aqZm3DKK6LNRVbUXB7yywx0ZpttqiBLnHmB1ayq2LRrE-UeQw_5iffP3_hoREDt1khW14hzOh2xdqhxJJFj-OVin3qq3iVyUoj4F2FUS0rr512TlUyc96XokKHxQnxBGZ1U_tnwJKV9nmFTkmuhMxtUZZ56a3PpHeruBIigmTAw9hQpZyaZfw23WlF5YYwNIQh_jJLYZYqgnfjnIu-Rsde6rcEsyEBxn-2ZchDwPVRKSxznAlNXbqUjuBwQomCZ6fDA8ImCP7GXMEbwetxmGZSMFvtm21HQ1XeUP_toxFZLCj0N4KnPe-Ne6P6BYXIkgiKCVeOBFQyfDpSn__qSodLOlEKXPr7gX-vLf2fn-z5_p2-gNvoRkrK0EzlIcza9da_hFv2sj3frF8FkfwLMgs-sA priority: 102 providerName: ProQuest |
| Title | Factors associated with return to work of breast cancer survivors: a systematic review |
| URI | https://link.springer.com/article/10.1186/1471-2458-14-S3-S8 https://www.ncbi.nlm.nih.gov/pubmed/25437351 https://www.proquest.com/docview/1627789585 https://www.proquest.com/docview/1629959005 https://www.proquest.com/docview/1635035330 https://pubmed.ncbi.nlm.nih.gov/PMC4251139 |
| Volume | 14 |
| WOSCitedRecordID | wos000345688700008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Engineering Database customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: M7S dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: PATMY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: 8C1 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3_a9QwFH-4TWQgfpnfqrNEEPxBi22TNom_zbFDwR3HquP8qbRNioPRk7ve_n7fS9tzPXSgv5SjeSm5vK9J3vsE4HVsOUpCqgPLrQwE2r9AhyIKTFKlxoYV8sUVCn-R06maz_WsLwpbDdnuw5Gks9ROrVX6PkIzGsQiwUWPCDIeZGoH9tDdKVLHs-x8c3YgVRIP5TF_7DdyQduG-Jon2s6S3DoqdR5ocv__xv4A7vURJzvqROQh3LLNAdw57c_UD-But3PHuoKkR3A-6a7gYUXPOWsY7daypUX31LB2wSiZiy1qVlJGe8sqkpwlW63R7Fxhzw-sYL8RollXHfMYvk1Ovh5_CvrbF4IqkaINauQtxlqhNqim5MbDsFShjW0dlomoNXLZwYpqUVtttDGqFomxtuA1RimG8yew2ywa-wxYVGqb1hiJpIqLtJJFkRa2somwpgxrzj2IBobkVQ9NTjdkXOZuiaLSnCYwpwnEX3nG80x58HbT52cHzHEj9Rvic05ai1-uir74AMdH-Ff5UcI1Xc2ltAeHI0rUtmrcPEhK3mv7Ko_SWEqlceXlwatNM_WkDLbGLtaOhqDd0OjdRMOTkFO-rwdPO-Hb_DcCLZA8iTyQI7HcEBBO-Lilufjh8MIFLSM5Dv3dIJzXhv7XKXv-b-QvYB9jSUFlmrE4hN12ubYv4XZ11V6slj7syLl0T4VPdRz5sPfxZDo7890miE8ptxm-m30-nX33nT7_AhS6PpA |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3rixMxEB-OnqAgvh-rp0ZQ_KDhdjfZ3UQQOdRy5Xql0FPOT3GbZPFAtmcfJ_5T_o3O7KN3Ldhv98FvhUzKZDPzm0kyD4AXsRcoCanmXviMS8Q_rkMZcZfY1PnQ4r5UicL9bDBQx8d6uAV_2lwYCqtsMbECajexdEe-G6VxlimN3u3705-cukbR62rbQqMWiwP_-xce2Wbveh9xf1_GcffT0Yd93nQV4DbJ5JwXyDP6EKF2KH5knsJwrEIf-yIcJ7LQyH1VLlPLwmunnVOFTJz3uSjQ-jq6AEXI35a4RNWB7WHvcPh1-W6RqSRuU3NUuhsh9PNYJnhQk3wk-EitmL91I3DBCq5HaK4901bWr3vzf_tut-BG42ezvVoxbsOWL-_A9fqSktW5V3fhS7fuNsTyRki9Y3QxzaYeLXHJ5hNGcWtsUrAxBe_PmSUlmbLZAhH2DGe-ZTk7L4bN6kSge_D5UpZ2HzrlpPQPgUVj7dMCna5UCZnaLM_T3FufSO_GYSFEAFG7_8Y2VdipGcgPU53GVGpIZgzJDP4yI2FGKoDXyzmndQ2SjdSvSKwMART-s82bPAvkj0p9mb1EaOpCpnQAOyuUCCx2dbiVKNMA28yci1MAz5fDNJOC9Uo_WVQ0VMUO8X0TjUhCQaHNATyoZX25NqrPkIkkCiBb0YIlAZVEXx0pT75XpdElnZgFsv6m1ZcLrP_zkz3avNJncHX_6LBv-r3BwWO4hi6zpGzUWO5AZz5d-CdwxZ7NT2bTpw0cMPh22Zr0Fzrzm3w |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ra9RAEB-0ShHER31Fq64g-MGGJtlNsuu3oh6K9ShES78tyT6wILlyl-vf70xeXg4tiN8COxs2O8_NzvwG4HXiOEpCpkLHXR4KtH-hikQc2tRk1kUG-dIWCh_n87k8O1MnG1X8bbb7cCXZ1TQQSlPdHF5Y36m4zA5jNKlhIlI8AImw4GEhr8MNQU2D6LxenI73CLlMk6FU5o_zJu5o2yhveKXtjMmta9PWG83u_v933IM7fSTKjjrRuQ_XXL0Hu1_7u_Y9uN390WNdodIDOJ11rXlY2XPUWUZ_cdnSoduqWbNglOTFFp5VlOneMEMStWSrNZqjS5z5jpXsN3I066pmHsL32cdv7z-FfVeG0KS5aEKPPMcYLFIW1ZfcexRVMnKJ81GVCq-Q-y3cqBLeKauslV6k1rmSe4xeLOePYKde1O4JsLhSLvMYoWSSi8zkZZmVzrhUOFtFnvMA4oE52vSQ5dQ546dujy4y07SBmjYQn3TBdSEDeDvOuegAO66kfkM816TN-GZT9kUJuD7CxdJHKVfUskuqAPYnlKiFZjo8SI3urcBKx1mS51LhiSyAV-MwzaTMttot1i0NQb6hMbyKhqcRpzzgAB53gjh-G4EZ5DyNA8gnIjoSEH74dKQ-_9HiiAs6XnJc-sEgqBtL_-uWPf038pewe_Jhpo8_z788g1sYbgqq5EzEPuw0y7V7DjfNZXO-Wr5oFfcXuDFCgw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+associated+with+return+to+work+of+breast+cancer+survivors%3A+a+systematic+review&rft.jtitle=BMC+public+health&rft.au=Islam%2C+Tania&rft.au=Dahlui%2C+Maznah&rft.au=Majid%2C+Hazreen+Abd&rft.au=Nahar%2C+Azmi+Mohamed&rft.date=2014-11-24&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=14&rft_id=info:doi/10.1186%2F1471-2458-14-S3-S8&rft.externalDocID=A539690189 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon |